CERVIDX

Live / Registered — International registration cancelled — extension of protection cancelled (as of 21 Sept 2016)

What this means for you

Registered since 29 Jul 2008. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79036313
Registration number
3476787
Mark type
Stylized text
Filed
20 Sept 2006
Published for opposition
05 Feb 2008
Registered
29 Jul 2008

Goods and services

  • Class 001 — Chemicals: Chemical preparations and reagents for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant cancerous conditions, malignant cancerous conditions, cancer and inborn deficiencies for scientific or research use
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous, conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents for detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic preparations, diagnostic immunocytochemical preparations, diagnostic immunohistochemical preparations, diagnostic histology preparations, diagnostic cytology preparations, diagnostic liquid-immuno-assay preparations, diagnostic solid-phase immuno-assay preparations, diagnostic testing strips, diagnostic dip-stick tests, diagnostic preparations for use at point of care, diagnostic lateral-flow assay preparations, diagnostic flow-through assay preparations, diagnostic immuno-chromatographic preparations; diagnostic equipment for medical purposes, namely, strips, cotton sticks, swabs, cotton and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above
  • Class 009 — Scientific and electric apparatus: Laboratory equipment for diagnostic purposes, namely, test tubes, multiwell test plates, multiwell ELISA (enzyme linked immunosorbent assay) plates and chromatography columns for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples
  • Class 010 — Medical apparatus: Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno-assay machines, diagnostic ELISA (enzyme linked immunosorbent assay) testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being for use in analyzing and providing diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic equipment for medical purposes, namely, syringes, needles, brushes, spatulas and sample receptacles for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid detection machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid amplification machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-histology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-cytology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic apparatus and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo imaging machines, all for for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; automated and non-automated cellular imaging devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated microscopy devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated imaging analysis devices for clinical and medical laboratory use for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies
  • Class 042 — Scientific and technological services: Scientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and medical diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services
  • Class 044 — Medical, beauty and agricultural services: Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Owner

Prosecution history

  • 26 Oct 2018 — UNDELIVERABLE MAIL - NO ACTION TAKEN
  • 20 Sept 2018 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
  • 20 Sept 2018 — DEATH OF INTERNATIONAL REGISTRATION
  • 05 Feb 2016 — TOTAL INVALIDATION PROCESSED BY THE IB
  • 14 Jan 2016 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 14 Jan 2016 — INVALIDATION PROCESSED
  • 06 Nov 2015 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 06 Mar 2015 — CANCELLED SECTION 71
  • 30 Dec 2012 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 02 Mar 2012 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 17 Nov 2008 — FINAL DISPOSITION NOTICE SENT TO IB
  • 17 Nov 2008 — FINAL DISPOSITION PROCESSED
  • 29 Oct 2008 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 29 Jul 2008 — REGISTERED-PRINCIPAL REGISTER
  • 20 Jun 2008 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

View this trademark record on Marksy